Project Details
Short title | A Phase II, Open-Label, Randomized, Multicentre Trial of GW786034(Pazopanib) in combination with Lapatinib (GW572016) compared to Lapatnib alone as first line of Therapy in Subjects with Advanced or Metastatic Breast Cancer with ErbB2 Fluor |
---|---|
Status | Finished |
Effective start/end date | 1/01/07 → 30/06/09 |
Funding
- Queen Elizabeth Hospital